Welch; Dennie S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Welch; Dennie S..The latest application filed is for "bcl-xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same".

Company Profile

6.11.16

Welch; Dennie S. - Gurnee IL
Welch; Dennie S. - Lake Bluff IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20200246460 - Kind Code	2020-08-06
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20200239553 - Ackler; Scott L. ; et al.	2020-07-30
Synthetic Route To Anti-viral Agents App 20200095230 - Cink; Russell D. ; et al.	2020-03-26
Synthetic route to anti-viral agents Grant 10,442,792 - Cink , et al. Oc	2019-10-15
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20190142941 - Ackler; Scott L. ; et al.	2019-05-16
Synthetic Route To Anti-viral Agents App 20190084966 - Cink; Russell D. ; et al.	2019-03-21
Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20180346484 - Akritopoulou-Zanze; Irini ; et al.	2018-12-06
Synthetic route to anti-viral agents Grant 10,077,256 - Cink , et al. September 18, 2	2018-09-18
Synthetic Route To Anti-viral Agents App 20180057482 - Cink; Russell D. ; et al.	2018-03-01
Modulators of 5-HT receptors and methods of use thereof Grant 9,879,033 - Akritopoulou-Zanze , et al. January 30, 2	2018-01-30
Synthetic route to anti-viral agents Grant 9,809,576 - Cink , et al. November 7, 2	2017-11-07
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors App 20170182179 - Ackler; Scott L. ; et al.	2017-06-29
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20160339117 - Ackler; Scott L. ; et al.	2016-11-24
Macrocyclic hepatitis C serine protease inhibitors Grant 9,493,506 - Chen , et al. November 15, 2	2016-11-15
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20160158377 - Ackler; Scott L. ; et al.	2016-06-09
Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20160096851 - Akritopoulou-Zanze; Irini ; et al.	2016-04-07
Modulators of 5-HT receptors and methods of use thereof Grant 9,187,483 - Akritopoulou-Zanze , et al. November 17, 2	2015-11-17
Modulators of 5-HT receptors and methods of use thereof Grant 8,846,951 - Akritopoulou-Zanze , et al. September 30, 2	2014-09-30
Macrocyclic Hepatitis C Serine Protease Inhibitors App 20140287992 - Chen; Hui-Ju ; et al.	2014-09-25
Macrocyclic hepatitis C serine protease inhibitors Grant 8,748,374 - Chen , et al. June 10, 2	2014-06-10
Macrocyclic Hepatitis C Serine Protease Inhibitors App 20120101031 - Chen; Hui-Ju ; et al.	2012-04-26
Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20110118231 - Akritopoulou-Zanze; Irini ; et al.	2011-05-19
Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20100298292 - Akritopoulou-Zanze; Irini ; et al.	2010-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.